Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$2.6 - $4.17 $53,934 - $86,502
-20,744 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.64 - $7.78 $75,508 - $161,388
20,744 New
20,744 $76,000
Q2 2021

Aug 12, 2021

SELL
$6.02 - $9.64 $113,344 - $181,501
-18,828 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$9.17 - $14.8 $172,652 - $278,654
18,828 New
18,828 $177,000

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.